Calming the cytokine storm in COVID-19 von Cron, Randy Q., Caricchio, Roberto, Chatham, W. Winn

Volltext

Long‐Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open‐Label Extension Study von Chatham, W. Winn, Furie, Richard, Saxena, Amit, Brohawn, Philip, Schwetje, Erik, Abreu, Gabriel, Tummala, Raj

Volltext

Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations von Absher, Devin M, Li, Xinrui, Waite, Lindsay L, Gibson, Andrew, Roberts, Kevin, Edberg, Jeffrey, Chatham, W Winn, Kimberly, Robert P

Volltext

Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus von Wallace, Daniel J., Ginzler, Ellen M., Merrill, Joan T., Furie, Richard A., Stohl, William, Chatham, W. Winn, Weinstein, Arthur, McKay, James D., McCune, W. Joseph, Petri, Michelle, Fettiplace, James, Roth, David A., Ji, Beulah, Heath, Amy

Volltext

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis von Atisha‐Fregoso, Yemil, Malkiel, Susan, Harris, Kristina M., Byron, Margie, Ding, Linna, Kanaparthi, Sai, Barry, William T., Gao, Wendy, Ryker, Kristin, Tosta, Patti, Askanase, Anca D., Boackle, Susan A., Chatham, W. Winn, Kamen, Diane L., Karp, David R., Kirou, Kyriakos A., Sam Lim, S., Marder, Bradley, McMahon, Maureen, Parikh, Samir V., Pendergraft, William F., Podoll, Amber S., Saxena, Amit, Wofsy, David, Diamond, Betty, Smilek, Dawn E., Aranow, Cynthia, Dall’Era, Maria

Volltext

Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus von Stohl, William, Hiepe, Falk, Latinis, Kevin M., Thomas, Mathew, Scheinberg, Morton A., Clarke, Ann, Aranow, Cynthia, Wellborne, Frank R., Abud-Mendoza, Carlos, Hough, Douglas R., Pineda, Lilia, Migone, Thi-Sau, Zhong, Z. John, Freimuth, William W., Chatham, W. Winn

Volltext

Lupus nephritis correlates with B cell interferon-β, anti-Smith, and anti-DNA: a retrospective study von Alduraibi, Fatima, Fatima, Huma, Hamilton, Jennie A, Chatham, W Winn, Hsu, Hui-Chen, Mountz, John D

Volltext

Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine von Harris, Bethany D, Kuruganti, Srilalitha, Deshpande, Ashlesha, Goepfert, Paul A, Chatham, W Winn, Walter, Mark R

Volltext

Macrophage Activation Syndrome in the Setting of Rheumatic Diseases von Chatham, W. Winn

Volltext

Cytokine Storm Syndrome von Cron, Randy Q, Goyal, Gaurav, Chatham, W. Winn

Volltext

Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort von Urowitz, Murray B., Gladman, Dafna D., Farewell, Vernon, Su, Jiandong, Romero-Diaz, Juanita, Bae, Sang-Cheol, Fortin, Paul R., Sanchez‐Guerrero, Jorge, Clarke, Ann Elaine, Bernatsky, Sasha, Gordon, Caroline, Hanly, John G., Wallace, Daniel J., Isenberg, David A., Rahman, Anisur, Merrill, Joan T., Ginzler, Ellen, Alarcón, Graciela S., Chatham, W. Winn, Petri, Michelle A., Bruce, Ian N., Khamashta, Munther A., Aranow, Cynthia, Dooley, Mary Anne, Manzi, Susan, Ramsey‐Goldman, Rosalind, Nived, Ola, Jönsen, Andreas, Steinsson, Kristján, Zoma, Asad A., Ruiz-Irastorza, Guillermo, Lim, S. Sam, Kalunian, Kenneth C., Ỉnanç, Murat, Vollenhoven, Ronald, Ramos‐Casals, Manuel, Kamen, Diane L., Jacobsen, Soren, Peschken, Christine A., Askanase, Anca, Stoll, Thomas

Volltext

Novel evidence‐based systemic lupus erythematosus responder index von Furie, Richard A., Petri, Michelle A., Wallace, Daniel J., Ginzler, Ellen M., Merrill, Joan T., Stohl, William, Chatham, W. Winn, Strand, Vibeke, Weinstein, Arthur, Chevrier, Marc R., Zhong, Z. John, Freimuth, William W.

Volltext

Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial von Singh, Jasvinder A, Fraenkel, Liana, Green, Candace, Alarcón, Graciela S, Barton, Jennifer L, Saag, Kenneth G, Hanrahan, Leslie M, Raymond, Sandra C, Kimberly, Robert P, Leong, Amye L, Reyes, Elyse, Street, Jr, Richard L, Suarez-Almazor, Maria E, Eakin, Guy S, Marrow, Laura, Morgan, Charity J, Caro, Brennda, Sloan, Jeffrey A, Jandali, Bochra, Garcia, Salvador R, Grossman, Jennifer, Winthrop, Kevin L, Trupin, Laura, Dall'Era, Maria, Meara, Alexa, Rizvi, Tara, Chatham, W Winn, Yazdany, Jinoos

Volltext

A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus von Wallace, Daniel J., Stohl, William, Furie, Richard A., Lisse, Jeffrey R., McKay, James D., Merrill, Joan T., Petri, Michelle A., Ginzler, Ellen M., Chatham, W. Winn, McCune, W. Joseph, Fernandez, Vivian, Chevrier, Marc R., Zhong, Z. John, Freimuth, William W.

Volltext

Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus von Kalunian, Kenneth C., Chatham, W. Winn, Massarotti, Elena M., Reyes-Thomas, Joyce, Harris, Cole, Furie, Richard A., Chitkara, Puja, Putterman, Chaim, Gross, Rachel L., Somers, Emily C., Kirou, Kyriakos A., Ramsey-Goldman, Rosalind, Hsieh, Christine, Buyon, Jill P., Dervieux, Thierry, Weinstein, Arthur

Volltext

Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial von Shakoory, Bita, Carcillo, Joseph A, Chatham, W Winn, Amdur, Richard L, Zhao, Huaqing, Dinarello, Charles A, Cron, Randall Q, Opal, Steven M

Volltext

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis von Saag, Kenneth G., Teng, Gim Gee, Patkar, Nivedita M., Anuntiyo, Jeremy, Finney, Catherine, Curtis, Jeffrey R., Paulus, Harold E., Mudano, Amy, Pisu, Maria, Elkins‐Melton, Mary, Outman, Ryan, Allison, Jeroan J., Almazor, Maria Suarez, Bridges, S. Louis, Chatham, W. Winn, Hochberg, Marc, Maclean, Catherine, Mikuls, Ted, Moreland, Larry W., O'dell, James, Turkiewicz, Anthony M., Furst, Daniel E.

Volltext

A phase III, randomized, placebo‐controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus von Furie, Richard, Petri, Michelle, Zamani, Omid, Cervera, Ricard, Wallace, Daniel J., Tegzová, Dana, Sanchez‐Guerrero, Jorge, Schwarting, Andreas, Merrill, Joan T., Chatham, W. Winn, Stohl, William, Ginzler, Ellen M., Hough, Douglas R., Zhong, Z. John, Freimuth, William, van Vollenhoven, Ronald F.

Volltext

Vasculitis related to viral and other microbial agents von Teng, Gim Gee, Chatham, W. Winn

Volltext

Mimicking the mimicker: Necrotizing sarcoid granulomatosis von Tran, Thao, Muhammad, Hazim, Chatham, W Winn, Crowe, David, Gaffo, Angelo

Volltext